Clopidogrel: A Case for Indication-Specific Pharmacogenetics

Authors:

Abstract
The CYP2C19*2 loss‐of‐function allele is associated with reduced generation of active metabolites of clopidogrel. However, meta‐analyses have supported or discounted the impact of genotype on adverse...

This publication has 10 references indexed in Scilit: